{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T00:20:13Z","timestamp":1769818813961,"version":"3.49.0"},"reference-count":77,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T00:00:00Z","timestamp":1655942400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>After the beginning of COVID-19 vaccination campaigns, several reports of thyroid disease possibly related to the COVID-19 vaccination progressively appeared in the literature, raising the question of whether the thyroid disorder might be a SARS-CoV-2 vaccine complication. The aim of this study was to analyze the data about COVID-19 vaccination and thyroid disease, evaluate the size and quality of related literature, assess the type of these events, and investigate their timing of onset with respect the vaccination. Pubmed\/MEDLINE and Cochrane were systematically reviewed until February 2022 to retrieve the largest number of original papers, case reports, and case series articles reporting thyroid disease after SARS-CoV-2 vaccination. Forty-six articles were included with a total of 99 patients aged from 26 to 73 years were described, of whom 74.75% female. Regarding the vaccination received, 49.49% of patients received Comirnaty (Pfizer\/BioNTech), 14.14% CoronaVac (Sinovac), 12.12% Vaxzevria (Oxford\/Astrazeneca), 11.11% Spikevax (Moderna), 3.03% Ad26.COV2.S (Janssen, Johnson &amp;amp; Johnson), one patient Covaxin (Bharat Biotech) and one patient Convidecia (Cansino). In 7 cases the thyroid disorder developed after the third dose with a combination of different vaccines. Regarding the type of thyroid disorder, 59 were subacute thyroiditis (SAT), 29 Graves\u2019 disease (GD), 2 co-occurrence of SAT and GD, 6 painless thyroiditis (PT), and single cases of thyroid eye disease and hypothyroidism associated with mixedema. The timeline between vaccination and thyroid disorder ranged between 0.5 to 60 days, with an average of 10.96 days. Considering the limited follow-up time, a complete remission was reported in most of SAT and PT cases while a persistence was observed in GD. In conclusion, both size and quality of published data about thyroid inconveniences after COVID-19 vaccination are limited; thyroid disorders may occur within 2 months after COVID-19 vaccination; among all thyroid diseases after COVID-19 vaccination, GD and SAT seem to be more frequent.<\/jats:p>","DOI":"10.3389\/fendo.2022.900964","type":"journal-article","created":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:23:11Z","timestamp":1655961791000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":17,"title":["Thyroid Inconveniences With Vaccination Against SARS-CoV-2: The Size of the Matter. A Systematic Review"],"prefix":"10.3389","volume":"13","author":[{"given":"Verdiana","family":"Caironi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabi\u00e1n","family":"Pitoia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierpaolo","family":"Trimboli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,23]]},"reference":[{"key":"B1","unstructured":"Laboratory-Confirmed COVID-19-Associated Hospitalizations"},{"key":"B2","unstructured":"The Impact of COVID-19 on Employment and Jobs"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00947-8","article-title":"Impact and Effectiveness of mRNA BNT162b2 Vaccine Against SARS-CoV-2 Infections and COVID-19 Cases, Hospitalisations, and Deaths Following a Nationwide Vaccination Campaign in Israel: An Observational Study Using National Surveillance Data","volume":"397","author":"Haas","year":"2021","journal-title":"Lancet 05 15"},{"key":"B4","unstructured":"COVID19 Vaccine Tracker"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3390\/ph14050406","article-title":"COVID-19 Vaccines: A Review of the Safety and Efficacy of Current Clinical Trials","volume":"14","author":"Yan","year":"2021","journal-title":"Pharm (Basel)"},{"key":"B6","unstructured":"Results of COVID-19 Vaccine Effectiveness Studies: An Ongoing Systematic Review"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)00152-0","article-title":"Duration of Effectiveness of Vaccines Against SARS-CoV-2 Infection and COVID-19 Disease: Results of a Systematic Review and Meta-Regression","volume":"399","author":"Feikin","year":"2022","journal-title":"Lancet"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0140-6736(20)32661-1","article-title":"Safety and Efficacy of the ChAdOx1 Ncov-19 Vaccine (AZD1222) Against SARS-CoV-2: An Interim Analysis of Four Randomised Controlled Trials in Brazil, South Africa, and the UK","volume":"397","author":"Voysey","year":"2021","journal-title":"Lancet"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2113017","article-title":"Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase","volume":"385","author":"El Sahly","year":"2021","journal-title":"N Engl J Med"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.11124\/JBISRIR-D-19-00099","article-title":"Methodological Quality of Case Series Studies: An Introduction to the JBI Critical Appraisal Tool","volume":"18","author":"Munn","year":"2020","journal-title":"JBI Evid Synth"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.778964","article-title":"Development of Graves' Disease After SARS-CoV-2 mRNA Vaccination: A Case Report and Literature Review","volume":"9","author":"Lui","year":"2021","journal-title":"Front Public Health"},{"key":"B14","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1530\/EDM-21-0142","article-title":"Subacute Thyroiditis Post-Pfizer-BioNTech mRNA Vaccination for COVID-19","volume":"2021","author":"Khan","year":"2021","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246425","article-title":"COVID-19 Vaccine-Associated Subacute Thyroiditis: An Unusual Suspect for De Quervain's Thyroiditis","volume":"14","author":"Jeeyavudeen","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.737142","article-title":"Case Report: Two Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccination","volume":"8","author":"Bornemann","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02879-8","article-title":"Aggravation of Hyperthyroidism After Heterologous Prime-Boost Immunization With Inactivated and Adenovirus-Vectored SARS-CoV-2 Vaccine in a Patient With Graves' Disease","volume":"74","author":"Sriphrapradang","year":"2021","journal-title":"Endocrine"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.aace.2021.12.002","article-title":"Thyroiditis After Coronavirus Disease 2019 (COVID-19) mRNA Vaccine: A Case Series","volume":"8","author":"Pandya","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-244711","article-title":"Subacute Thyroiditis After Inactive SARS-CoV-2 Vaccine","volume":"14","author":"Sayg\u0131l\u0131","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejim.2021.10.008","article-title":"COVID-19 Vaccination and a Severe Pain in the Neck","volume":"94","author":"Kyriacou","year":"2021","journal-title":"Eur J Intern Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000002059","article-title":"Thyroid Eye Disease Following COVID-19 Vaccine in a Patient With a History Graves' Disease: A Case Report","volume":"37","author":"Rubinstein","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab373","article-title":"Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine: Postvaccination ASIA Syndrome","volume":"106","author":"\u0130remli","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1177\/23247096211063356","article-title":"Graves Disease Following the SARS-CoV-2 Vaccine: Case Series","volume":"9","author":"Weintraub","year":"2021","journal-title":"J Investig Med High Impact Case Rep"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ccr3.5217","article-title":"Acute Thyroid Swelling With Severe Hypothyroid Myxoedema After COVID-19 Vaccination","volume":"9","author":"Giusti","year":"2021","journal-title":"Clin Case Rep"},{"key":"B25","doi-asserted-by":"publisher","first-page":"e04812","DOI":"10.1002\/ccr3.4812","article-title":"Subacute Thyroiditis Following COVID-19 Vaccination","volume":"9","author":"Soltanpoor","year":"2021","journal-title":"Clin Case Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.metop.2021.100136","article-title":"Thyroiditis Following Vaccination Against COVID-19: Report of Two Cases and Review of the Literature","volume":"12","author":"Siolos","year":"2021","journal-title":"Metabol Open"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.12890\/2021_002807","article-title":"Recurrence of Graves' Disease (a Th1-Type Cytokine Disease) Following SARS-CoV-2 mRNA Vaccine Administration: A Simple Coincidence","volume":"8","author":"Pierman","year":"2021","journal-title":"Eur J Case Rep Intern Med"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9101108","article-title":"A Case of Exacerbation of Subclinical Hyperthyroidism After First Administration of BNT162b2 mRNA COVID-19 Vaccine","volume":"9","author":"Yamamoto","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.1947102","article-title":"Subacute Thyroiditis Following COVID-19 Vaccination in a 67-Year-Old Male Patient: A Case Report","volume":"17","author":"\u015eahin Tekin","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.4045\/tidsskr.21.0554","article-title":"Subacute Thyroiditis After Vaccination Against SARS-CoV-2","volume":"141","author":"Sigstad","year":"2021","journal-title":"Tidsskr Nor Laegeforen"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-246432","article-title":"Graves' Disease Following Administration of Second Dose of SARS-CoV-2 Vaccine","volume":"14","author":"Goblirsch","year":"2021","journal-title":"BMJ Case Rep"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2021.2013083","article-title":"COVID-19 mRNA Vaccine may Trigger Subacute Thyroiditis","volume":"17","author":"S\u00f6zen","year":"2021","journal-title":"Hum Vaccin Immunother"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/8952048","article-title":"A Case Report of Subacute Thyroiditis Following mRNA COVID-19 Vaccine","volume":"2021","author":"Plaza-Enriquez","year":"2021","journal-title":"Case Rep Endocrinol"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.16045","article-title":"Subacute Thyroiditis After Receiving the Adenovirus-Vectored Vaccine for Coronavirus Disease (COVID-19)","volume":"13","author":"Oyibo","year":"2021","journal-title":"Cureus"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab822","article-title":"Letter to the Editor From Raven: Three Cases of Subacute Thyroiditis Following SARS-CoV-2 Vaccine","volume":"107","author":"Raven","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.medcli.2021.11.002","article-title":"Subacute Thyroiditis After SARS-CoV-2 Vaccination: Report of Two Clinical Cases","author":"Gonz\u00e1lez L\u00f3pez","year":"2021","journal-title":"Med Clin (Barc)"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/j.eimc.2021.10.015","article-title":"Tiroiditis Subaguda Despues De La Vacuna Anti-SARS-CoV-2 (Ad5-Ncov)","author":"Rebollar","year":"2021","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1080\/09273948.2021.1961815","article-title":"Acute Thyroiditis and Bilateral Optic Neuritis Following SARS-CoV-2 Vaccination With CoronaVac: A Case Report","volume":"29","author":"Leber","year":"2021","journal-title":"Ocul Immunol Inflamm"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02898-5","article-title":"Thyrotoxicosis After COVID-19 Vaccination: Seven Case Reports and a Literature Review","volume":"74","author":"Lee","year":"2021","journal-title":"Endocrine"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2021.102738","article-title":"A Case of Graves' Disease and Type 1 Diabetes Mellitus Following SARS-CoV-2 Vaccination","volume":"125","author":"Patrizio","year":"2021","journal-title":"J Autoimmun"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2021.0142","article-title":"Two Cases of Graves' Disease Following SARS-CoV-2 Vaccination: An Autoimmune\/Inflammatory Syndrome Induced by Adjuvants","volume":"31","author":"Vera-Lastra","year":"2021","journal-title":"Thyroid"},{"key":"B42","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1089\/thy.2021.0184","article-title":"Thyroiditis and Thyrotoxicosis After the SARS-CoV-2 mRNA Vaccine","volume":"31","author":"Schimmel","year":"2021","journal-title":"Thyroid"},{"key":"B43","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1007\/s40618-021-01725-y","article-title":"Silent Thyroiditis Following Vaccination Against COVID-19: Report of Two Cases","volume":"45","author":"Capezzone","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01739-0","article-title":"Thyrotoxicosis Following SARS-COV-2 Vaccination: A Case Series and Discussion","volume":"45","author":"Pla Peris","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1016\/j.crwh.2021.e00378","article-title":"Recurring Subacute Thyroiditis After SARS-CoV-2 mRNA Vaccine: A Case Report","volume":"33","author":"Vasileiou","year":"2022","journal-title":"Case Rep Womens Health Jan"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01681-7","article-title":"Post-COVID-Vaccine Autoimmune\/Inflammatory Syndrome in Response to Adjuvants (ASIA Syndrome) Manifesting as Subacute Thyroiditis","volume":"45","author":"Das","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-021-00332-z","article-title":"Subacute Thyroiditis After SARS-CoV-2 Vaccination: A Report of Two Sisters and Summary of the Literature","volume":"21","author":"Chatzi","year":"2022","journal-title":"Hormones (Athens)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s42000-021-00346-7","article-title":"Painless Thyroiditis Following mRNA Vaccination for COVID-19","author":"Nakaizumi","year":"2022","journal-title":"Hormones (Athens)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jecr.2021.100104","article-title":"A Case Report of New Onset Graves' Disease Induced by SARS-CoV-2 Infection or Vaccine","volume":"23","author":"Hamouche","year":"2022","journal-title":"J Clin Transl Endocrinol Case Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjoto.2021.103211","article-title":"SARS-CoV-2 Vaccine-Induced Subacute Thyroiditis","volume":"43","author":"Patel","year":"2022","journal-title":"Am J Otolaryngol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01650-0","article-title":"Two Further Cases of Graves' Disease Following SARS-Cov-2 Vaccination","volume":"45","author":"Zettinig","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B52","doi-asserted-by":"publisher","first-page":"97","DOI":"10.20945\/2359-3997000000430","article-title":"Two Cases of Subacute Thyroiditis After Different Types of SARS-CoV-2 Vaccination","volume":"66","author":"Bostan","year":"2022","journal-title":"Arch Endocrinol Metab"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2022.37.e39","article-title":"Subacute Thyroiditis After Receiving the mRNA COVID-19 Vaccine (Moderna): The First Case Report and Literature Review in Korea","volume":"37","author":"Jhon","year":"2022","journal-title":"J Korean Med Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgac049","article-title":"SARS-CoV-2 Vaccine-Induced Thyroiditis: Safety of Re-Vaccinations and Clinical Follow-Up","volume":"107","author":"O\u011fuz","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12020-021-02919-3","article-title":"Occurrence and Response to Treatment of Graves' Disease After COVID Vaccination in Two Male Patients","volume":"75","author":"di Filippo","year":"2022","journal-title":"Endocrine"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048","article-title":"Subacute Thyroiditis After mRNA Vaccine for Covid-19","volume":"5","author":"Franquemont","year":"2021","journal-title":"J Endocrine Society"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-021-01707-0","article-title":"Thyroid as a Target of Adjuvant Autoimmunity\/Inflammatory Syndrome Due to mRNA-Based SARS-CoV2 Vaccination: From Graves' Disease to Silent Thyroiditis","volume":"45","author":"Pujol","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"B58","unstructured":"WHO Coronavirus (COVID-19) Dashboard"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1007\/s40618-022-01747-0","article-title":"SARS-CoV-2 Vaccine-Associated Subacute Thyroiditis: Insights From a Systematic Review","volume":"45","author":"Ippolito","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_237_18","article-title":"Occurrence of Subacute Thyroiditis Following Influenza Vaccination","volume":"22","author":"Passah","year":"2018","journal-title":"Indian J Endocrinol Metab"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2015.1117716","article-title":"Subacute Thyroiditis Following Seasonal Influenza Vaccination","volume":"12","author":"Altay","year":"2016","journal-title":"Hum Vaccin Immunother"},{"key":"B62","first-page":"48","article-title":"Subacute Thyroiditis and Dyserythropoesis After Influenza Vaccination Suggesting Immune Dysregulation","volume":"103","author":"Hern\u00e1n Martinez","year":"2011","journal-title":"Bol Asoc Med P R"},{"key":"B63","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/BF03346633","article-title":"Subacute Thyroiditis Following the H1N1 Vaccine","volume":"33","author":"Girgis","year":"2010","journal-title":"J Endocrinol Invest"},{"key":"B64","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/s1607-551x(09)70315-8","article-title":"Subacute Thyroiditis Following Influenza Vaccine (Vaxigrip) in a Young Female","volume":"22","author":"Hsiao","year":"2006","journal-title":"Kaohsiung J Med Sci"},{"key":"B65","first-page":"135","article-title":"Subacute Thyroiditis After Hepatitis B Vaccination","volume":"45","author":"Toft","year":"1998","journal-title":"Endocr J"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/joim.12694","article-title":"Human Papillomavirus Vaccination of Adult Women and Risk of Autoimmune and Neurological Diseases","volume":"283","author":"Hviid","year":"2018","journal-title":"J Intern Med"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1097\/INF.0000000000002569","article-title":"Systematic Review and Meta-Analysis of Postlicensure Observational Studies on Human Papillomavirus Vaccination and Autoimmune and Other Rare Adverse Events","volume":"39","author":"Willame","year":"2020","journal-title":"Pediatr Infect Dis J"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4931","article-title":"Association Between Human Papillomavirus Vaccination and Serious Adverse Events in South Korean Adolescent Girls: Nationwide Cohort Study","volume":"372","author":"Yoon","year":"2021","journal-title":"BMJ"},{"key":"B69","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.jaut.2017.01.005","article-title":"Risk of Autoimmune Diseases and Human Papilloma Virus (HPV) Vaccines: Six Years of Case-Referent Surveillance","volume":"79","author":"Grimaldi-Bensouda","year":"2017","journal-title":"J Autoimmun"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.12182\/20211160506","article-title":"[Subacute Thyroiditis Following HPV Vaccination: A Case Report]","volume":"52","author":"Xie","year":"2021","journal-title":"Sichuan Da Xue Xue Bao Yi Xue Ban"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.617089","article-title":"Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases","volume":"11","author":"Vojdani","year":"2020","journal-title":"Front Immunol"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and Autoimmune Disease: What is the Evidence","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.03.011","article-title":"By-Stander Activation in Autoimmune Thyroiditis: Studies on Experimental Autoimmune Thyroiditis in the GFP+ Fluorescent Mouse","volume":"121","author":"Arata","year":"2006","journal-title":"Clin Immunol"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589833","article-title":"Adjuvants for Coronavirus Vaccines","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2016.00150","article-title":"Autoimmune\/Inflammatory Syndrome Induced by Adjuvants and Thyroid Autoimmunity","volume":"7","author":"Watad","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.3390\/vaccines9080815","article-title":"Vaccinations and Autoimmune Diseases","volume":"9","author":"Olivieri","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.840668","article-title":"Patients With Autoimmune Thyroiditis Present Similar Immunological Response to COVID-19 BNT162b2 mRNA Vaccine With Healthy Subjects, While Vaccination May Affect Thyroid Function: A Clinical Study","volume":"13","author":"Paschou","year":"2022","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.900964\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T05:23:26Z","timestamp":1655961806000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.900964\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,23]]},"references-count":77,"alternative-id":["10.3389\/fendo.2022.900964"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.900964","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,23]]},"article-number":"900964"}}